Muyni
← Back to Washington

Health Public Hearing

Regular Meeting

Washington, DC · July 13, 2023

Agenda

Agenda

COUNCIL OF THE DISTRICT OF COLUMBIA COMMITTEE ON HEALTH NOTICE OF PUBLIC HEARING 1350 Pennsylvania Avenue, NW, Washington, DC 20004 REVISED COUNCILMEMBER CHRISTINA HENDERSON, CHAIRPERSON COMMITTEE ON HEALTH ANNOUNCES A PUBLIC HEARING ON B25-0073, the "Ambulatory Surgical Facility Amendment Act of 2023;" B25-226, the "Access to Emergency Albuterol & Glucagon Amendment Act of 2023;" AND B25-0312, the “Health Professional Licensing Boards Residency Requirement Amendment Act of 2023” ON Thursday July 13, 2023, 10:00 a.m. Virtual Meeting via Zoom Video Conference Broadcast To Watch Live: https://dccouncil.gov/council-videos/ https://www.christinahendersondc.com/live https://www.youtube.com/@cmchenderson Councilmember Christina Henderson, Chair of the Committee on Health, announce a hearing on B25-0073, the "Ambulatory Surgical Facility Amendment Act of 2023;" B25-226, the "Access to Emergency Albuterol & Glucagon Amendment Act of 2023;" and B25-0312, the “Health Professional Licensing Boards Residency Requirement Amendment Act of 2023.” The hearing will be held at 10:00 a.m. on Thursday July 13, 2023. The purpose B25-73 is to amend the Health-Care and Community Residence Facility, Hospice and Home Care Licensure Act of 1983 to update the definitions for ambulatory surgical facility and ambulatory surgery and repeal the requirement that the regulations list all procedures that may only be performed in an ambulatory surgical facility. The purpose of B25-226 is to require OSSE to create an action plan that authorizes schools to possess and administer undesignated albuterol (asthma) and glucagon (diabetes) in emergencies. It would also require schools to have at least 2 doses of each drug and require at least 2 school staff to be trained in administering these drugs. The purposed of B25-312 is to require that at least 50% of Health Professional Licensing Board positions designated for professional members be filled by District residents at the time of their appointments and while they are members of the board. It also requires that the professional members of each Board be licensed for the health occupation regulated by the Board on which they sit and engaged in the practice of that health occupation in the District for at least 3 years preceding their appointment. It also requires that members who are not District residents be engaged in the practice of the health occupation regulated by the Board in the District while they are members of the Board. Those who wish to testify must register at http://bit.do/HealthHearings by 5:00 p.m. on Tuesday July 11. Those representing an organization will have 5 minutes to speak. All other witnesses will have 3 minutes to peak. Witnesses who anticipate needing spoken language interpretation, or require sign language interpretation, are requested to inform the Committee office of the need as soon as possible but no later than five business days before the proceeding. We will make every effort to fulfill timely requests, although alternatives may be offered. Requests received in less than five business days may not be fulfilled. If you have additional questions, please email Ashley Strange, Legislative Assistant at astrannge@dccouncil.gov. The hearing will be conducted virtually on the Internet utilizing Zoom video conference technology. Testimony should be submitted in writing to astrange@dccouncil.gov in advance of the hearing. If you are unable to testify at the hearing, written statements are encouraged and will be made a part of the official record. Statements for the record should be submitted to astrange@dccouncil.gov. The record will close at 5:00pm on Thursday, July 27, 2023. This notice has been revised to include the addition of a bill, B25-0312 - Health Professional Licensing Boards Residency Requirement Amendment Act of 2023

Get email alerts for Washington

A daily email when new agendas and minutes are posted.

Report an issue with this meeting